Anthony Ferrari

1.2k total citations
15 papers, 376 citations indexed

About

Anthony Ferrari is a scholar working on Oncology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Anthony Ferrari has authored 15 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Pathology and Forensic Medicine and 6 papers in Cancer Research. Recurrent topics in Anthony Ferrari's work include Genetic factors in colorectal cancer (6 papers), Cancer Genomics and Diagnostics (5 papers) and Colorectal Cancer Treatments and Studies (3 papers). Anthony Ferrari is often cited by papers focused on Genetic factors in colorectal cancer (6 papers), Cancer Genomics and Diagnostics (5 papers) and Colorectal Cancer Treatments and Studies (3 papers). Anthony Ferrari collaborates with scholars based in France, United States and Belgium. Anthony Ferrari's co-authors include Daniel Birnbaum, Arnaud Lagarde, José Adélaı̈de, Pascal Finetti, François Bertucci, Patrice Viens, Geneviève Monges, Max Chaffanet, Sylviane Olschwang and Janice Kielbassa and has published in prestigious journals such as Nature Communications, PLoS ONE and European Urology.

In The Last Decade

Anthony Ferrari

14 papers receiving 374 citations

Peers

Anthony Ferrari

ONCOL

PFM

PRM

Melanie Isau Germany

Daniel Kerr United States

Zarina Yelskaya United States

Simone Maistro Brazil

Paulo Rodrigues Spain

Xiaomei Sui China

Mike Radonovich United States

Makiko Sakata Japan

Thomas Liggett United States

Shazia Irshad United Kingdom

Melanie Isau Germany

Anthony Ferrari

192 ×1.0

217 ×1.4

144 ×1.0

ONCOL

132 ×1.4

PFM

67 ×1.0

PRM

Citations per year, relative to Anthony Ferrari Anthony Ferrari (= 1×) peers Melanie Isau

Countries citing papers authored by Anthony Ferrari

Since Specialization

Citations

This map shows the geographic impact of Anthony Ferrari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Ferrari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Ferrari more than expected).

Fields of papers citing papers by Anthony Ferrari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony Ferrari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Ferrari. The network helps show where Anthony Ferrari may publish in the future.

Co-authorship network of co-authors of Anthony Ferrari

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony Ferrari. A scholar is included among the top collaborators of Anthony Ferrari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony Ferrari. Anthony Ferrari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Tonon, Laurie, Dominique Poujol, Émilie Picard, et al.. (2025). Interleukin-35 impairs human NK cell effector functions and induces their ILC1-like conversion with tissue residency features. Nature Communications. 16(1). 6135–6135.

Poncet, Delphine, Pierre‐Paul Bringuier, Dominik Sturm, et al.. (2024). Characteristics of H3K27M-mutant diffuse gliomas with a non-midline location. Journal of Neuro-Oncology. 169(2). 391–398. 3 indexed citations

Dufresne, Armelle, Valéry Attignon, Anthony Ferrari, et al.. (2024). Added value of whole‐exome and RNA sequencing in advanced and refractory cancer patients with no molecular‐based treatment recommendation based on a 90‐gene panel. Cancer Medicine. 13(7). e7115–e7115. 1 indexed citations

Pommier, Roxane M., Amélien Sanlaville, Laurie Tonon, et al.. (2020). Comprehensive characterization of claudin-low breast tumors reflects the impact of the cell-of-origin on cancer evolution. Nature Communications. 11(1). 3431–3431. 68 indexed citations

Tonon, Laurie, Gaëlle Fromont, Sandrine Boyault, et al.. (2018). Mutational Profile of Aggressive, Localised Prostate Cancer from African Caribbean Men Versus European Ancestry Men. European Urology. 75(1). 11–15. 28 indexed citations

Saintigny, Pierre, Jean‐Philippe Foy, Anthony Ferrari, et al.. (2016). Apport et défis des Big Data en cancérologie. Bulletin du Cancer. 104(3). 281–287. 1 indexed citations

Ferrari, Anthony, Anne-Sophie Sertier, Anne Vincent‐Salomon, et al.. (2016). A phenotypic and mechanistic perspective on heterogeneity of HER2-positive breast cancers. Molecular & Cellular Oncology. 3(6). e1232186–e1232186. 5 indexed citations

Grandval, Philippe, Aurélie Fabre, Pascaline Gaildrat, et al.. (2013). UMD-MLH1/MSH2/MSH6 databases: description and analysis of genetic variations in French Lynch syndrome families. Database. 2013(0). bat036–bat036. 14 indexed citations

Birnbaum, David, Anthony Ferrari, Arnaud Lagarde, et al.. (2012). Expression Profiles in Stage II Colon Cancer According to APC Gene Status. Translational Oncology. 5(2). 72–76. 16 indexed citations

10.

Bertucci, François, Arnaud Lagarde, Anthony Ferrari, et al.. (2012). 8q24 Cancer Risk Allele Associated with Major Metastatic Risk in Inflammatory Breast Cancer. PLoS ONE. 7(5). e37943–e37943. 36 indexed citations

11.

Lagarde, Arnaud, et al.. (2012). A Seven-Gene Signature Aggregates a Subgroup of Stage II Colon Cancers with Stage III. OMICS A Journal of Integrative Biology. 16(10). 560–565. 56 indexed citations

12.

Bekhouche, Ismahane, Pascal Finetti, José Adélaı̈de, et al.. (2011). High-Resolution Comparative Genomic Hybridization of Inflammatory Breast Cancer and Identification of Candidate Genes. PLoS ONE. 6(2). e16950–e16950. 49 indexed citations

13.

Adélaı̈de, José, Pascal Finetti, Nathalie Cervera, et al.. (2010). Loss, mutation and deregulation of L3MBTL4 in breast cancers. Molecular Cancer. 9(1). 213–213. 43 indexed citations

14.

Sabatier, Renaud, José Adélaı̈de, Pascal Finetti, et al.. (2010). BARD1 homozygous deletion, a possible alternative to BRCA1 mutation in basal breast cancer. Genes Chromosomes and Cancer. 49(12). 1143–1151. 22 indexed citations

15.

Lagarde, Arnaud, Etienne Rouleau, Anthony Ferrari, et al.. (2010). Germline APC mutation spectrum derived from 863 genomic variations identified through a 15-year medical genetics service to French patients with FAP: Figure 1. Journal of Medical Genetics. 47(10). 721–722. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact